DULIGOTUZUMAB

UNII: 8PMF8YQX2T
Preferred Substance Name: DULIGOTUZUMAB

1314238-96-4
BISPECIFIC HUMANIZED IGG1 MONOCLONAL ANTIBODY TO EPIDERMAL GROWTH FACTOR RECEPTOR AND HER3
DULIGOTUMAB
DULIGOTUZUMAB [INN]
DULIGOTUZUMAB [USAN]
DULIGOTUZUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR/EPIDERMAL GROWTH FACTOR RECEPTOR 3) (HUMAN MONOCLONAL MEHD7945A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEHD7945A LIGHT CHAIN, DIMER
MEHD7945A
MEHD-7945A
RG7597
RG-7597

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

DULIGOTUZUMAB

Synonyms and Mappings

Resources

Note